Home
/
Praxis Precision Medicines, Inc.
/
Financials
/
Quarterly
Praxis Precision Medicines, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Praxis Precision Medicines, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$0
Nov 5, 2025
Q2
2025
Jun 30, 2025
$0
Aug 4, 2025
Q1
2025
Mar 31, 2025
$0
May 2, 2025
Q3
2025
Sep 30, 2024
$302.0K
Nov 5, 2025
Q2
2025
Jun 30, 2024
$357.0K
Aug 4, 2025
Q1
2025
Mar 31, 2024
$431.0K
May 2, 2025
Q3
2024
Sep 30, 2023
$468.0K
Nov 6, 2024
Q2
2024
Jun 30, 2023
$781.0K
Aug 13, 2024
Q1
2024
Mar 31, 2023
$683.0K
May 13, 2024
Q3
2023
Sep 30, 2022
$0
Nov 7, 2023
Q2
2023
Jun 30, 2022
$0
Aug 9, 2023
Q1
2023
Mar 31, 2022
$0
May 11, 2023
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($73.93M)
Nov 5, 2025
Q3
2025
Jun 30, 2025
($71.13M)
Nov 5, 2025
Q2
2025
Jun 30, 2025
($71.13M)
Aug 4, 2025
Q1
2025
Mar 31, 2025
($69.30M)
May 2, 2025
Q2
2025
Mar 31, 2025
($69.30M)
Aug 4, 2025
Q3
2025
Mar 31, 2025
($69.30M)
Nov 5, 2025
Q3
2025
Sep 30, 2024
($51.91M)
Nov 5, 2025
Q2
2025
Jun 30, 2024
($32.68M)
Aug 4, 2025
Q3
2025
Jun 30, 2024
($32.68M)
Nov 5, 2025
Q3
2025
Mar 31, 2024
($39.55M)
Nov 5, 2025
Q2
2025
Mar 31, 2024
($39.55M)
Aug 4, 2025
Q1
2025
Mar 31, 2024
($39.55M)
May 2, 2025
Q3
2024
Sep 30, 2023
($24.63M)
Nov 6, 2024
Q2
2024
Jun 30, 2023
($34.31M)
Aug 13, 2024
Q3
2024
Jun 30, 2023
($34.31M)
Nov 6, 2024
Q3
2024
Mar 31, 2023
($37.46M)
Nov 6, 2024
Q1
2024
Mar 31, 2023
($37.46M)
May 13, 2024
Q2
2024
Mar 31, 2023
($37.46M)
Aug 13, 2024
Q3
2023
Sep 30, 2022
($43.95M)
Nov 7, 2023
Q2
2023
Jun 30, 2022
($60.19M)
Aug 9, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($78.36M)
Nov 5, 2025
Q2
2025
Jun 30, 2025
($76.07M)
Aug 4, 2025
Q1
2025
Mar 31, 2025
($74.73M)
May 2, 2025
Q3
2025
Sep 30, 2024
($56.84M)
Nov 5, 2025
Q2
2025
Jun 30, 2024
($37.49M)
Aug 4, 2025
Q1
2025
Mar 31, 2024
($41.89M)
May 2, 2025
Q3
2024
Sep 30, 2023
($25.52M)
Nov 6, 2024
Q2
2024
Jun 30, 2023
($34.96M)
Aug 13, 2024
Q1
2024
Mar 31, 2023
($38.09M)
May 13, 2024
Q3
2023
Sep 30, 2022
($44.29M)
Nov 7, 2023
Q2
2023
Jun 30, 2022
($60.39M)
Aug 9, 2023
Q1
2023
Mar 31, 2022
($68.85M)
May 11, 2023
Q3
2022
Sep 30, 2021
($44.77M)
Nov 9, 2022
Q2
2022
Jun 30, 2021
($36.48M)
Aug 8, 2022
Q1
2022
Mar 31, 2021
($27.42M)
May 9, 2022
Q3
2021
Sep 30, 2020
($16.22M)
Nov 3, 2021
Q2
2021
Jun 30, 2020
($11.57M)
Aug 16, 2021
Q1
2021
Mar 31, 2020
($8.47M)
May 11, 2021
Q3
2020
Sep 30, 2019
($10.65M)
Nov 23, 2020